Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.
Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL; STICHES Investigators. Velazquez EJ, et al. N Engl J Med. 2016 Apr 21;374(16):1511-20. doi: 10.1056/NEJMoa1602001. Epub 2016 Apr 3. N Engl J Med. 2016. PMID: 27040723 Free PMC article. Clinical Trial.
[A patient with aortic stenosis and reduced left ventricular function].
Broch K, Gude E, Scott H, Aakhus S. Broch K, et al. Among authors: gude e. Tidsskr Nor Laegeforen. 2009 Oct 22;129(20):2119-21. doi: 10.4045/tidsskr.08.0622. Tidsskr Nor Laegeforen. 2009. PMID: 19855451 Free article. Norwegian. No abstract available.
Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial.
Andreassen AK, Broch K, Eiskjær H, Karason K, Gude E, Mølbak D, Stueflotten W, Gullestad L; SCHEDULE (SCandinavian HEart transplant everolimus De-novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators. Andreassen AK, et al. Among authors: gude e. Transplantation. 2019 Apr;103(4):781-788. doi: 10.1097/TP.0000000000002445. Transplantation. 2019. PMID: 30211826 Clinical Trial.
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection.
Trøseid M, Mayerhofer CCK, Broch K, Arora S, Svardal A, Hov JR, Andreassen AK, Gude E, Karason K, Dellgren G, Berge RK, Gullestad L, Aukrust P, Ueland T. Trøseid M, et al. Among authors: gude e. J Heart Lung Transplant. 2019 Oct;38(10):1097-1103. doi: 10.1016/j.healun.2019.06.003. Epub 2019 Jun 19. J Heart Lung Transplant. 2019. PMID: 31301965
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial.
Broch K, Gude E, Karason K, Dellgren G, Rådegran G, Gjesdal G, Gustafsson F, Eiskjaer H, Lommi J, Pentikäinen M, Lemström KB, Andreassen AK, Gullestad L. Broch K, et al. Among authors: gude e. Clin Transplant. 2020 Sep;34(9):e13984. doi: 10.1111/ctr.13984. Epub 2020 Aug 6. Clin Transplant. 2020. PMID: 32445429 Clinical Trial.
100 results